IMPROVEMENT OF PROGNOSIS IRRESPECTIVE OF AGE IN EARLY NODE-NEGATIVE EARLY BREAST-CANCER BY ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL
C. Focan et al., IMPROVEMENT OF PROGNOSIS IRRESPECTIVE OF AGE IN EARLY NODE-NEGATIVE EARLY BREAST-CANCER BY ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 56-56